We are live on ! Find out more
RG

Redmile Group Portfolio holdings

AUM $1.49B
1-Year Est. Return 208.7%
This Fund
S&P 500
This Quarter Est. Return
-5.41%
1 Year Est. Return
+208.7%
3 Year Est. Return
+777.5%
5 Year Est. Return
+1,114.43%
10 Year Est. Return
+23,630.52%
AUM
$7.1B
AUM Growth
-$1.16B
Cap. Flow
-$291M
Cap. Flow %
-4.1%
Top 10 Hldgs %
41.94%
Holding
104
New
17
Increased
24
Reduced
34
Closed
18

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$151M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$136M
3
MDT icon
Medtronic
MDT
+$115M
4
DXCM icon
DexCom
DXCM
+$83.5M
5
LIVN icon
LivaNova
LIVN
+$79.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$149M
2
GILD icon
Gilead Sciences
GILD
+$133M
3
ONEM
1Life Healthcare
ONEM
+$129M
4
BEAM icon
Beam Therapeutics
BEAM
+$119M
5
SNY icon
Sanofi
SNY
+$96.4M

Sector Composition

Rank Sector Weight
1 Healthcare 98.86%
2 Financials 0.83%
3 Consumer Staples 0.3%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LVTX
51
DELISTED
LAVA Therapeutics
LVTX
$42.9M 0.6%
+2,824,409
New +$38.8M
UNH icon
52
UnitedHealth
UNH
$355B
$42.6M 0.6%
114,376
-110,263
-49% -$38.2M
BCEL
53
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$38.2M 0.54%
2,490,568
+14,500
+0.6% +$236K
AMED
54
DELISTED
Amedisys
AMED
$35.2M 0.5%
132,980
-500
-0.4% -$141K
ACHL
55
DELISTED
Achilles Therapeutics
ACHL
$34.6M 0.49%
+2,088,089
New +$34.6M
RCEL icon
56
Avita Medical
RCEL
$319M
$33.1M 0.47%
1,668,327
-39,059
-2% -$908K
CTLT
57
DELISTED
CATALENT, INC.
CTLT
$32.8M 0.46%
311,619
-2,900
-0.9% -$323K
ZYME icon
58
Zymeworks
ZYME
$2.07B
$31.1M 0.44%
985,700
-102,600
-9% -$4.17M
PPD
59
DELISTED
PPD, Inc. Common Stock
PPD
$31.1M 0.44%
821,092
-2,100
-0.3% -$75.3K
HOOK
60
DELISTED
HOOKIPA Pharma
HOOK
$24.8M 0.35%
184,290
– –
IMTX icon
61
Immatics
IMTX
$1.28B
$23.3M 0.33%
2,082,814
+14,513
+0.7% +$165K
ARDX icon
62
Ardelyx
ARDX
$986M
$23.3M 0.33%
3,514,100
– –
GRTS
63
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$23.1M 0.33%
2,448,158
-611,636
-20% -$8.42M
BVS icon
64
Bioventus
BVS
$942M
$22.9M 0.32%
+1,500,000
New +$21.4M
ITMR
65
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$22M 0.31%
918,900
+207,400
+29% +$4.93M
ONEM
66
DELISTED
1Life Healthcare
ONEM
$22M 0.31%
562,314
-2,746,880
-83% -$129M
INNV icon
67
InnovAge Holding
INNV
$1.5B
$21.9M 0.31%
+850,000
New +$20.9M
STXS icon
68
Stereotaxis
STXS
$147M
$21.8M 0.31%
3,241,603
+138,276
+4% +$821K
SKIN icon
69
SkinHealth Systems
SKIN
$90M
$21.4M 0.3%
1,982,749
+982,749
+98% +$10.8M
CTSO icon
70
Cytosorbents Corp
CTSO
$21.4M
$18.5M 0.26%
2,127,631
+73,500
+4% +$701K
QTRX icon
71
Quanterix
QTRX
$125M
$17.5M 0.25%
+300,000
New +$20.3M
PROF
72
Profound Medical
PROF
$254M
$17M 0.24%
845,674
+20,477
+2% +$491K
KA
73
DELISTED
Kineta, Inc. Common Stock
KA
$11.1M 0.16%
87,286
– –
QURE icon
74
uniQure
QURE
$3.44B
$9.57M 0.13%
284,160
-744,738
-72% -$26.7M
DVAX
75
DELISTED
Dynavax Technologies
DVAX
$8.68M 0.12%
882,814
-334,030
-27% -$2.75M
1 2
3
4 5

Similar funds

FCM
Fairholme Capital Management South Miami, Florida $1.49B AUM 28.35% 1-Year Est. Return
MM
Main Management San Francisco, California $1.49B AUM 22.28% 1-Year Est. Return
WA
WBH Advisory Baltimore, Maryland $1.49B AUM 20.41% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.49B AUM 32.81% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
GAM
Gemmer Asset Management Walnut Creek, California $1.49B AUM 42.66% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $1.49B AUM 26.43% 1-Year Est. Return
PMG
ProVise Management Group Clearwater, Florida $1.49B AUM 21.79% 1-Year Est. Return

Redmile Group's Q1 2021 Portfolio in Review

As of Q1 2021, Redmile Group held 104 positions worth $7.1B, down 14% from $8.26B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Redmile Group withdrew a net $291M in Q1 2021, closing 18 positions and reducing 34 holdings. Its most notable exit was AbbVie, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 99% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Redmile Group opened a new position in Seagen Inc. Common Stock worth $130M.

  • Redmile Group's largest Q1 2021 buy was Seagen Inc. Common Stock: 937,045 shares worth $130M.
  • Redmile Group added most to Fate Therapeutics in Q1 2021, an estimated $31.4M increase.
  • Redmile Group's biggest Q1 2021 reduction was 1Life Healthcare, cutting an estimated $129M.
  • Redmile Group fully exited AbbVie in Q1 2021, selling an estimated $149M.
  • Redmile Group's ten largest holdings make up 42% of its $7.1B portfolio in Q1 2021.
  • Redmile Group opened 17 new positions and closed 18 in Q1 2021.
  • Redmile Group's portfolio value fell 14% quarter-over-quarter to $7.1B.

Based on Redmile Group's 13F filing for Q1 2021, filed 17 May 2021.